Akoya Biosciences's market cap is currently $102.12M. The company's EPS TTM is $-1.176; its P/E ratio is ―; Akoya Biosciences is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 96.63M	$ 74.86M	$ 54.92M	$ 42.44M	$ 42.24M
Gross Profit	$ 56.30M	$ 43.39M	$ 34.22M	$ 25.91M	$ 24.66M
Operating Income	$ -57.67M	$ -66.21M	$ -37.23M	$ -11.49M	$ -13.50M
EBITDA	$ -45.63M	$ -58.81M	$ -35.17M	$ -10.13M	$ -9.62M
Net Income	$ -63.32M	$ -70.64M	$ -42.94M	$ -16.71M	$ -14.75M
Balance Sheet
Cash & Short-Term Investments	$ 83.13M	$ 81.22M	$ 113.08M	$ 17.01M	$ 21.66M
Total Assets	$ 180.37M	$ 176.03M	$ 190.91M	$ 77.66M	$ 89.41M
Total Debt	$ 85.71M	$ 75.78M	$ 32.47M	$ 34.99M	$ 24.75M
Net Debt	$ 2.58M	$ 1.55M	$ -80.61M	$ 17.99M	$ 13.12M
Total Liabilities	$ 126.60M	$ 117.45M	$ 69.56M	$ 59.09M	$ 119.57M
Stockholders' Equity	$ 53.77M	$ 58.58M	$ 121.35M	$ 18.57M	$ -30.16M
Cash Flow
Free Cash Flow	$ -54.55M	$ -60.86M	$ -41.16M	$ -10.14M	$ -16.64M
Operating Cash Flow	$ -50.90M	$ -53.50M	$ -36.07M	$ -6.84M	$ -13.78M
Investing Cash Flow	$ 3.35M	$ -14.08M	$ -5.09M	$ 6.73M	$ -12.89M
Financing Cash Flow	$ 56.84M	$ 28.73M	$ 137.03M	$ 5.49M	$ 28.56M

Currency in USD

Akoya Biosciences Earnings and Revenue History

Income Statement >

Akoya Biosciences Debt to Assets

Balance Sheet >

Akoya Biosciences Cash Flow

Cash Flow >

Akoya Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing